Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors

Shilo, Konstantin; Xin Wu; Sharma, Smita; Welliver, Meng; Wenrui Duan; Villalona-Calero, Miguel; Junya Fukuoka; Sif, Said; Baiocchi, Robert; Hitchcock, Charles L.; Weiqiang Zhao; Otterson, Gregory A.
January 2013
Diagnostic Pathology;2013, Vol. 8 Issue 1, p1
Academic Journal
Background Protein arginine methyltransferase-5 (PRMT5) is a chromatin-modifying enzyme capable of methylating histone and non-histone proteins, and is involved in a wide range of cellular processes that range from transcriptional regulation to organelle biosynthesis. As such, its overexpression has been linked to tumor suppressor gene silencing, enhanced tumor cell growth and survival. Material and methods Quantitative real-time polymerase chain reaction, Western immunoblot and immunohistochemistry were used to characterize PRMT5 expression in lung cancer cell lines and human tumors. Clinicopathological findings of tissue microarray based samples from 229 patients with non-small cell lung carcinomas (NSCLC) and 133 cases with pulmonary neuroendocrine tumors (NET) were analyzed with regard to nuclear and cytoplasmic PRMT5 expression. Results There was statistically significant difference in PRMT5 messenger RNA expression between tumors and nonneoplastic lung tissues. Immunoblot experiments showed abundant expression of PRMT5 and its symmetric methylation mark H4R3 in lung carcinoma but not in non- neoplastic human pulmonary alveolar and bronchial epithelial cell lines. More than two thirds of lung tumors expressed PRMT5. High levels of cytoplasmic PRMT5 were detected in 20.5% of NSCLC and in 16.5% of NET; high levels of nuclear PRMT5 were detected in 38.0% of NSCLC and 24.0% of NET. Cytoplasmic PRMT5 was associated with high grade in both NSCLC and pulmonary NET while nuclear PRMT5 was more frequent in carcinoid tumors (p < 0.05). Conclusion The observed findings support the role of PRMT5 in lung tumorigenesis and reflect its functional dichotomy in cellular compartments.


Related Articles

  • Cross-talk among epigenetic modifications: lessons from histone arginine methylation. Molina-Serrano, Diego; Schiza, Vassia; Kirmizis, Antonis // Biochemical Society Transactions;Jun2013, Vol. 41 Issue 3, p751 

    Epigenetic modifications, including those occurring on DNA and on histone proteins, control gene expression by establishing and maintaining different chromatin states. In recent years, it has become apparent that epigenetic modifications do not function alone, but work together in various...

  • Recognizing methylated histone variant H3.3 to prevent tumors. Venkatesh, Swaminathan; Workman, Jerry L // Cell Research;Jun2014, Vol. 24 Issue 6, p649 

    Regulatory information stored in modified histones is functionally translated by effector proteins ('readers'), which identify the histone mark to determine the specificity of the response. A recent study identifying the tumor suppressor protein ZMYND11 as an exclusive reader of methylated...

  • The Arginine Methyltransferase PRMT6 Cooperates with Polycomb Proteins in Regulating HOXA Gene Expression. Stein, Claudia; Nötzold, René Reiner; Riedl, Stefanie; Bouchard, Caroline; Bauer, Uta-Maria // PLoS ONE;2/5/2016, Vol. 11 Issue 2, p1 

    Protein arginine methyltransferase 6 (PRMT6) catalyses asymmetric dimethylation of histone H3 at arginine 2 (H3R2me2a), which has been shown to impede the deposition of histone H3 lysine 4 trimethylation (H3K4me3) by blocking the binding and activity of the MLL1 complex. Importantly, the genomic...

  • MicroRNA-181 Regulates CARM1 and Histone Aginine Methylation to Promote Differentiation of Human Embryonic Stem Cells. Zhenyu Xu; Junfeng Jiang; Chen Xu; Yue Wang; Lei Sun; Xiaocan Guo; Houqi Liu // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    As a novel epigenetic mechanism, histone H3 methylation at R17 and R26, which is mainly catalyzed by coactivator-associated protein arginine methyltransferase 1 (CARM1), has been reported to modulate the transcription of key pluripotency factors and to regulate pluripotency in mouse embryos and...

  • Large-Cell Lung Carcinoma With Basaloid Architecture and Neuroendocrine Differentiation: A New Type of Combined Large-Cell Neuroendocrine Carcinoma. Morbini, Patrizia; Inghilleri, Simona // International Journal of Surgical Pathology;04/01/2011, Vol. 19 Issue 2, p252 

    One of the main differential diagnostic issues in pulmonary large-cell carcinomas is that involving neuroendocrine (NE) and basaloid histotypes. The differential diagnosis of basaloid versus large-cell NE carcinoma requires immunohistochemical determination of NE markers because of morphological...

  • Recruitment of Rpd3 to the Telomere Depends on the Protein Arginine Methyltransferase Hmt1. Milliman, Eric J.; Yadav, Neelu; Yin-Chu Chen; Muddukrishna, Bhavana; Karunanithi, Sheelarani; Yu, Michael C.; Lustig, Arthur J. // PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1 

    In the yeast Saccharomyces cerevisiae, the establishment and maintenance of silent chromatin at the telomere requires a delicate balance between opposing activities of histone modifying enzymes. Previously, we demonstrated that the protein arginine methyltransferase Hmt1 plays a role in the...

  • Rb at the Interface Between Cell Cycle and Apoptotic Decisions. Delston, Rachel B.; William Harbour, J. // Current Molecular Medicine;Nov2006, Vol. 6 Issue 7, p713 

    The retinoblastoma (RB) gene was the first tumor suppressor to be identified, and it continues to be the subject of intense scientific interest. Not only is the RB gene mutated in the rare eye tumor and some other cancers, the Rb protein is functionally inactivated in virtually all human...

  • Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation. Prickett, Todd D; Zerlanko, Brad J; Hill, Victoria K; Gartner, Jared J; Qutob, Nouar; Jiang, Jiji; Simaan, May; Wunderlich, John; Gutkind, J Silvio; Rosenberg, Steven A; Samuels, Yardena // Journal of Investigative Dermatology;Sep2014, Vol. 134 Issue 9, p2390 

    The ionotropic glutamate receptors (N-methyl-D-aspartate receptors (NMDARs)) are composed of large complexes of multi-protein subunits creating ion channels in the cell plasma membranes that allow for influx or efflux of mono- or divalent cations (e.g., Ca2+) important for synaptic...

  • Selective activation of NFAT by promyelocytic leukemia protein. Lo, Y.-H.; Wu, C.-C.; Shih, H.-M.; Lai, M.-Z. // Oncogene;6/19/2008, Vol. 27 Issue 27, p3821 

    Promyelocytic leukemia (PML) protein is a tumor suppressor with complicated action mechanisms not yet fully understood. In this study, we found that the nuclear factor of activated T cell (NFAT) is an unexpected partner of PML: PML specifically enhanced the transcription activation of NFAT. In...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics